GSA Capital Partners’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,287
Closed -$533K 1863
2025
Q4
$533K Sell
20,287
-61,198
-75% -$1.59M 0.05% 765
2025
Q3
$1.84M Buy
81,485
+311
+0.4% +$6.41K 0.15% 103
2025
Q2
$1.61M Sell
81,174
-23,641
-23% -$461K 0.11% 198
2025
Q1
$1.77M Buy
104,815
+85,481
+442% +$1.46M 0.16% 103
2024
Q4
$357K Buy
+19,334
New +$377K 0.03% 1112
2024
Q3
Sell
-40,323
Closed -$791K 1737
2024
Q2
$791K Buy
+40,323
New +$842K 0.06% 672
2023
Q4
Sell
-24,636
Closed -$659K 1638
2023
Q3
$659K Buy
+24,636
New +$841K 0.06% 626
2021
Q1
Sell
-4,168
Closed -$217K 1230
2020
Q4
$217K Buy
+4,168
New +$174K 0.04% 933
2020
Q2
Sell
-10,109
Closed -$109K 770
2020
Q1
$109K Sell
10,109
-10,491
-51% -$146K 0.03% 883
2019
Q4
$266K Buy
+20,600
New +$245K 0.03% 1106
2017
Q2
Sell
-11,300
Closed -$123K 1755
2017
Q1
$123K Buy
+11,300
New +$134K 0.01% 1648

Other funds holding FLGT